Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma

Tran, L; Allen, CT; Xiao, R; Moore, E; Davis, R; Park, SJ; Spielbauer, K; Van Waes, C; Schmitt, NC

Schmitt, NC (reprint author), NIH, 10 Ctr Dr,Room 7N240B, Bethesda, MD 20892 USA.

CANCER IMMUNOLOGY RESEARCH, 2017; 5 (12): 1141

Abstract

Head and neck squamous cell carcinoma (HNSCC) has been treated for decades with cisplatin chemotherapy, and anti-PD-1 immunotherapy has recently been ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索